Andere talen Lepu Biopharma Co., Ltd.

Aandelen

2157

CNE100004SM4

Beurs gesloten - Hong Kong S.E. Andere beurzen 10:08:07 09-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
5,49 ^HKD	+0,37%		-11,31%	+30,40%

12/04	Keymed Biosciences boekt vooruitgang met geneesmiddel voor vaste tumoren in studie met eerste patiënt	MT
27/03	Lepu Biopharma Co, Ltd. Rapporteert winstresultaten voor het volledige jaar dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Keymed Biosciences Advances Solid Tumors Drug With First Patient Study	12/04
Lepu Biopharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	27/03
Lepu Biopharma's Pancreatic Cancer Drug Gets US FDA Fast-Track Designation	11/03
Lepu Biopharma Co., Ltd. Receives Fast Track Designation by the Food and Drug Administration of the United States for the Treatment of Pancreatic Cancer	11/03
Lepu Biopharma Shareholders to Vote Jan. 31 on Contract to Produce Drugs for Lepu Medical Technology	17/01
Lepu Biopharma Co., Ltd. Announces Completion of Patient Enrollment of Pivotal Phase IIb Clinical Trial for MRG003 for the Treatment of R/M NPC	28/12
Lepu Biopharma Completes Patient Enrollment for Phase 2B Trial for Nasopharyngeal Cancer Drug	29/12
Lepu Biopharma Renews Procurement Agreement With Lepu Medical Technology	26/12
Lepu Biopharma Gets US FDA's Orphan Drug Designation for Pancreatic Cancer Drug	14/12
Lepu Biopharma Co., Ltd. Announces Orphan-Drug Designation Granted by the FDA to MRG004A for the Treatment of Pancreatic Cancer	14/12
US FDA Grants Fast Track Designation to Lepu Biopharma's Anti-Cancer Drug	04/12
Lepu Biopharma to Provide Drug Production Services to Lepu Medical Technology	14/11
Lepu Biopharma Divests 15% Stake in Technical Services Provider	29-09-23
China Medical System Holdings Limited entered into the equity transfer agreement to acquire 15% stake in Hangzhou HealSun Biopharm Co., Ltd. from Lepu Biopharma Co., Ltd. for approximately CNY 130 million.	29-09-23
Lepu Biopharma Co., Ltd.(SEHK:2157) added to S&P Global BMI Index	18-09-23
Lepu Biopharma Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	25-08-23
Lepu Biopharma Seeks to Extend Validity of Secondary Listing in Shanghai	09-08-23
Stocks add to rebound; SSE ups earnings guidance	30-03-23
AstraZeneca Completes KYM Solid Tumors Treatment Deal	30-03-23
Lepu Biopharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	17-03-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Lepu Biopharma Co., Ltd.

Aandelen

2157

CNE100004SM4

Andere talen

Filters